Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 377 participants.
Also called NCT04702451
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 377 participants
- Sponsor
- Registry
-
NCT04702451
-
- Main results
- Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial
- Other papers using this trial's data
- Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, France, Germany, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT04702451. Randomized; double masking; primary purpose treatment. Start 2021-02-12 (actual); primary completion 2023-12-27 (actual). Results posted on 2025-09-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
- Acronym
- Tailored-AF
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- Dispersion ablation + PVI
- Intervention (Device)
- VX1
- Intervention (Procedure)
- PVI
- Lead sponsor
- Volta Medical
- Collaborator
- Fortrea
- Collaborator
- CardiaBase
Record details
- Record id
cardio:ct-nct04702451- Content hash
ac8fde3b4a4cd590a9c082abfa79e5be807dc2d80a157fee57110da032c1860d